EPGLD Medical Director and Chairman of Scientific
Post# of 1422
![Avatar](/images/ProfileImages/1205194238_2003_steeler obama.jpg)
EP Global Communications, Inc. (the Company) , (Pink Sheets: EPGL.PK), is pleased to announce the appointment of Corey W. Hunter M.D. to the position of Company Medical Director and Chairman of the Scientific Advisory Board. Dr. Hunter was pivotal in conducting early research on the MPDD device. Along with NYU physicians, Michel Dubois M.D. and Shengping Zou M.D., Dr. Hunter headed the team which published one of the first research studies showing significant improvement for the detection of pain caused by muscles, using the MPDD device versus traditional manual pressure (MP) for the diagnosis and treatment Myofascial Pain Syndrome which can include chronic back pain, neck pain, migraine, fybromyalgia and more. These findings greatly contributed to the early progress of the MPDD development and its subsequent FDA 510k clearance and patent awards.
http://www.prweb.com/releases/2012/7/prweb9685849.htm
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)